AN INNOVATIVE TARGETED ONCOLOGY COMPANY BUILT ON NEXT GENERATION ANTIBODY-DRUG CONJUGATES (ADC) AND A NOVEL DISCOVERY ENGINE
Live moderated webcast on Thursday, September 4th at 4:00 PM ET Access the event here BOSTON and LONDON – September 3, 2025 – Akari Therapeutics, Plc …
[Read more...] about Akari Therapeutics to Participate in the Virtual Investor Closing Bell Series
Live video webcast on Tuesday, August 19th at 2:00 PM ET BOSTON and LONDON – August 14, 2025 – Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology …
Abizer Gaslightwala, President and CEO of Akari Therapeutics discussed Akari’s commitment to continued research to better understand the multiple effects of its …
[Read more...] about Akari Therapeutics Releases Virtual Investor “What This Means” Segment
PH1 modulates RNA splicing, causing cancer cell death while activating the immune system to attack cancer throughout the body Company advancing pipeline of …
– Video webcast now available on-demand BOSTON and LONDON – July 22, 2025 – Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company …
